Peer Review History
| Original SubmissionNovember 6, 2025 |
|---|
|
-->PONE-D-25-57504-->-->Development of a Computerized Adaptive Test for ECG Interpretation Using Item Response Theory-->-->PLOS One Dear Dr. Inaba, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please note that we have only been able to secure a single reviewer to assess your manuscript. We are issuing a decision on your manuscript at this point to prevent further delays in the evaluation of your manuscript. Please be aware that the editor who handles your revised manuscript might find it necessary to invite additional reviewers to assess this work once the revised manuscript is submitted. However, we will aim to proceed on the basis of this single review if possible. -->--> -->-->Could you please revise the manuscript to carefully address the concerns raised? Please submit your revised manuscript by May 06 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:-->
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Helen Howard Staff Editor PLOS One Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please note that PLOS One has specific guidelines on code sharing for submissions in which author-generated code underpins the findings in the manuscript. In these cases, we expect all author-generated code to be made available without restrictions upon publication of the work. Please review our guidelines at https://journals.plos.org/plosone/s/materials-and-software-sharing#loc-sharing-code and ensure that your code is shared in a way that follows best practice and facilitates reproducibility and reuse. 3. Thank you for stating the following financial disclosure: [This study was funded by industrial seeds support from Ehime University, Ehime, Japan and by health care science institute, Tokyo, Japan.]. Please state what role the funders took in the study. If the funders had no role, please state: ""The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."" If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 4. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 5. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions -->Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. --> Reviewer #1: Partly ********** -->2. Has the statistical analysis been performed appropriately and rigorously? --> Reviewer #1: No ********** -->3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.--> Reviewer #1: No ********** -->4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.--> Reviewer #1: Yes ********** -->5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)--> Reviewer #1: I have carefully read the full manuscript, and I must acknowledge that it is a study with genuine scientific merit and practical relevance in the field of medical education and electrocardiography. The application of MIRT and the development of a CAT prototype represent an innovative approach that can contribute meaningfully to the standardization of ECG competency assessment. However, there are several points to which the authors should pay attention: 1. The title adequately reflects the content of the study, but it could benefit from greater methodological precision. It is recommended to specify that this is an initial validation study or a development phase, to prevent readers from assuming that the CAT is already fully validated and operational. 2. The introduction provides a clear context for the clinical relevance of the study, but there is some redundancy in the explanation of MIRT and CAT. It is recommended to simplify and avoid repetition to improve the overall flow. The statement that “no MIRT tools for ECG exist” should be nuanced with broader references, since there are previous approaches in medical education which, although not identical, could be considered as antecedents. 3.While the Supplemental Methods provide a clearer description of the participant profiles and the recruitment process at Ehime University, the manuscript would still benefit from a detailed demographic table. Specifically, the exact proportion of experts versus novices should be reported, as a skewed distribution in clinical expertise can significantly influence the stability of the a and b parameters during MIRT calibration. 4. The decision to fix the guessing parameter (c) at 0.2 requires a stronger justification. In practice, the probability of guessing varies considerably depending on the ECG pattern—for example, identifying a Wolf-Parkinson-White tracing is not comparable to recognizing a simple sinus rhythm. Fixing cat a constant value may oversimplify the reality of visual interpretation. The authors should clarify why 0.2 was chosen, whether sensitivity analyses with alternative values were performed, and discuss whether an estimated parameter or a 2PL model might have provided a more realistic representation of the data. 5. A key assumption of IRT is that success on one item should not condition success on another. Since in an ECG one finding (e.g., peaked T waves) is often linked to another (e.g., QRS widening in hyperkalemia), the authors should confirm whether they performed local dependence tests (such as Yen’s Q3) to validate this assumption. 6. The reporting of model fit indices in Table 2 presents two critical inconsistencies. First, while the bifactor (2-factor) model shows superior fit according to AIC (28966 vs. 29077) and log-likelihood (–14283 vs. –14388), the unidimensional model was selected based primarily on BIC (29719 vs. 29823). From a methodological standpoint, AIC indicates that a specific factor structure may better explain the variance, and the authors should discuss why parsimony was prioritized over improved fit, especially given that ECG interpretation is clinically multidimensional. Second, the 5-factor bifactor model reports a chi-square value of –69 with 0 degrees of freedom, which is mathematically invalid and suggests either non-convergence of the estimation algorithm or an over-identified (saturated) model. This invalidates direct statistical comparison using chi-square tests. The authors should clarify whether the 5-factor model was discarded due to convergence issues or insufficient sample size (n = 535), and it is recommended to report this model as “non-convergent” or “misidentified” rather than presenting fit statistics that lack mathematical validity. 7. Upon reviewing the data integrity, inconsistencies were noted between the statistics reported in Figure 1 and Table 2 for the same models. Specifically, the AIC for the unidimensional model varies from 29,180 to 29,077, while its log-likelihood ranges from -14,490 to -14,388; this suggests a potential discrepancy arising from different analysis stages or software executions. This inconsistency extends to the Results section, where the unidimensional model is described as having the best fit and the lowest log-likelihood. However, the data in Table 2 indicate that the two-factor Bifactor model is superior in terms of both AIC (28,966) and logLik (-14,283). Therefore, further clarification is required regarding the criteria used to prioritize BIC parsimony over a more complex model structure that appears to offer a better statistical fit. 8. Although the parameter calibration is described in detail, items Q33, Q43, and Q50 show low discriminatory power, which suggests the need to reassess their relevance within the item bank. In addition, to strengthen methodological transparency, it is recommended that the authors provide the numerical values of the Zh fit statistics in a formal table, rather than relying solely on qualitative descriptions or supplementary figures. 9. Figure 3A shows two items whose behavior deviates drastically from the expected correlation (outliers) between difficulty and success rate. Given the clinical nature of the study, it is imperative to describe the content of these items. Identifying whether they involved tracings with artifacts or ambiguous diagnoses is crucial for refining the item bank. 10. The discussion emphasizes the usefulness of the unidimensional model, but it would benefit from a deeper analysis of why the models based on physiological categories showed poor fit. It would be valuable to consider whether this outcome is due to an uneven distribution of items across categories or whether ECG interpretation truly reflects an integrated, non-fragmented cognitive process. Furthermore, although items Q33, Q43, and Q50 were identified as having low discriminatory power, the discussion does not outline an action plan for them; it is important to note that in psychometrics, items with low discrimination can bias the estimation of ability, making it necessary to evaluate whether their inclusion in the item bank is appropriate. Finally, while the psychometric efficiency of the CAT prototype is evident, the manuscript should also address the need for future criterion validity studies that compare system results with the actual clinical performance of professionals in direct patient care settings. 11. The limitations are well identified, but they should also include the potential lack of international representativeness of the sample, given that recruitment was conducted primarily in Japan. The conclusion states that the CAT may enable standardized evaluation, but this should be qualified by noting that it remains a preliminary prototype not yet validated in clinical practice. Likewise, the assertion that the unidimensional model provides the “best fit” should be nuanced and presented as a “practical simplification for the initial prototype,” while acknowledging that the fit indices (AIC) suggest the multidimensional nature of ECG interpretation has not yet been fully captured by the current model. 12. The example item in Supplemental Figure 1 illustrates a critical flaw in item construction. The clinical vignette presents a loss of consciousness and a heart rate of 22 bpm, findings that share a logical clinical correlation. However, a fundamental physiopathological dilemma arises extreme bradycardia in the context of hyperkalemia characteristically occurs when the condition is severe, a stage where the QRS complex is expected to be very wide and bizarre. In contrast, this tracing shows a QRS duration under 120 ms, lacking the markers of severity required to explain such profound clinical compromise solely through potassium toxicity. Consequently, an experienced physician might observe the small deflection preceding the QRS in the frontal leads—suggesting a low-amplitude P-wave and a prolonged PR interval—and reasonably prioritize a diagnosis of extreme sinus bradycardia as the most consistent explanation for the clinical data, even if hyperkalemia is present. While some might still argue for hyperkalemia, this level of clinical debate is precisely what a standardized assessment should avoid. For a Computerized Adaptive Testing (CAT) system to be valid, the diagnostics must be unequivocal and resolved beforehand. Any item that allows for competing, clinically sound interpretations penalizes advanced reasoning and introduces noise that undermines the reliability of the ability estimation 13. Finally, I suggest that the authors enrich the article by including the following bibliographic references: Carmona-Puerta R, Lorenzo-Martínez E. The issue of electrocardiography interpretation competence revisited. Educación Médica Superior. 2025; 39: e4563. Available from: https://ems.sld.cu/index.php/ems/article/view/4563/1612 Carmona-Puerta R, Lorenzo-Martínez E. Electrocardiography teaching methods. Educación Médica Superior. 2025; 39: e4558. Available from: https://ems.sld.cu/index.php/ems/article/view/4558/1610 ********** -->6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.--> Reviewer #1: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. |
| Revision 1 |
|
<div>PONE-D-25-57504R1-->-->Development and Initial Validation of a Computerized Adaptive Test Prototype for ECG Interpretation Using Item Response Theory-->-->PLOS One Dear Dr. Inaba, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. The manuscript has been evaluated by two reviewers, and their comments are available below. The reviewers have raised a number of concerns that need attention. Could you please revise the manuscript to carefully address the concerns raised? Please submit your revised manuscript by Aug 06 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:-->
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. As the corresponding author, your ORCID iD is verified in the submission system and will appear in the published article. PLOS supports the use of ORCID, and we encourage all coauthors to register for an ORCID iD and use it as well. Please encourage your coauthors to verify their ORCID iD within the submission system before final acceptance, as unverified ORCID iDs will not appear in the published article. Only the individual author can complete the verification step; PLOS staff cannot verify ORCID iDs on behalf of authors. We look forward to receiving your revised manuscript. Kind regards, Johanna Pruller, Ph.D. Senior Editor PLOS One Journal Requirements: If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions -->Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.--> Reviewer #1: All comments have been addressed Reviewer #2: (No Response) ********** -->2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. --> Reviewer #1: Yes Reviewer #2: Yes ********** -->3. Has the statistical analysis been performed appropriately and rigorously? --> Reviewer #1: Yes Reviewer #2: Yes ********** -->4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.--> Reviewer #1: Yes Reviewer #2: Yes ********** -->5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.--> Reviewer #1: Yes Reviewer #2: Yes ********** -->6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)--> Reviewer #1: The authors have successfully and thoroughly addressed all the comments and concerns raised during the first round of review. The manuscript has improved significantly, the methodology is sound, and I have no further comments. I am happy to recommend this manuscript for publication in PLOS One. Reviewer #2: interesting paper. Some issues should be added. briefly I think the paper is interesting but needs more data to fit clinicians 1) from the abstract to the paper the present work sounds really technical and hard to be understood from physicians. maybe it should be repharaed 2) also the clinical aim of the introduction should be made more easy to be understood 3)maybe a figure summarizing one process may be of great help 4) the results are very hard to be understood from physicians and should been made more expkainable 5) The 5-factor bifactor model reports a chi-square value of –69 with 0 degrees of freedom, which is not interpretable. This model should be explicitly labeled as non-identifiable, unstable, or unsuitable for inferential comparison. Presenting its chi-square statistic in the same way as the other models may mislead readers. I recommend either removing the chi-square result for this model or marking it as “not interpretable.” 6) The sample includes cardiologists, non-cardiologists, technologists, nurses, students, and other healthcare professionals. This heterogeneity is useful, but the manuscript only describes expertise categories descriptively. Given that item parameters can be influenced by subgroup composition, the authors should consider whether differential item functioning was assessed across relevant groups, particularly experts versus novices or physicians versus non-physicians. At minimum, the absence of DIF analysis should be acknowledged as a limitation. ********** -->7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.--> Reviewer #1: No Reviewer #2: Yes: Fabrizio D'Ascenzo ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. |
| Revision 2 |
|
Development and Initial Validation of a Computerized Adaptive Test Prototype for ECG Interpretation Using Item Response Theory PONE-D-25-57504R2 Dear Dr. Shinji Inaba, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Leander Luiz Klein, Ph.D. Academic Editor PLOS One Additional Editor Comments (optional): The current version of the manuscript was improved according the suggestions of the reviewers. Both of them suggested to accept the article with no additional sugestions. -->Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.--> Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** -->2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. --> Reviewer #1: Yes Reviewer #2: (No Response) ********** -->3. Has the statistical analysis been performed appropriately and rigorously? --> Reviewer #1: Yes Reviewer #2: (No Response) ********** -->4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.--> Reviewer #1: Yes Reviewer #2: (No Response) ********** -->5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.--> Reviewer #1: Yes Reviewer #2: (No Response) ********** -->6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)--> Reviewer #1: (No Response) Reviewer #2: (No Response) ********** -->7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.--> Reviewer #1: No Reviewer #2: Yes: Fabrizio D'Ascenzo ********** |
| Formally Accepted |
|
PONE-D-25-57504R2 PLOS One Dear Dr. Inaba, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Professor Leander Luiz Klein Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .